SCHEMBL24575366

SCHEMBL24575366

Nc1nnc(Cl)c2cnccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.42
AXL P30530 1/20 0.40
EP300 Q09472 1/20 0.40
KAT2B Q92831 1/20 0.40
KAT8 Q9H7Z6 1/20 0.40
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CHUK O15111 2/20 0.37
TBK1 Q9UHD2 1/20 0.36
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
RAD52 P43351 1/20 0.34
ACHE P22303 1/20 0.33
TDO2 P48775 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30771962 0.92 IMPDH2 (0.43) IMPDH2KDM4EGAAAXLEP300
SCHEMBL24575364 0.92 IMPDH2 (0.43) IMPDH2KDM4EGAAAXLEP300
SCHEMBL793650 0.85 IMPDH2 (0.41) IMPDH2KDM4EGAAAXLEP300
SCHEMBL31468033 0.85 IMPDH2 (0.41) IMPDH2KDM4EGAAAXLEP300
SCHEMBL30502565 0.76 KDM4E (0.43) IMPDH2KDM4EGAAAXLEP300
SCHEMBL25254434 0.76 EP300 (0.40) IMPDH2KDM4EGAAAXLEP300
SCHEMBL16274537 0.76 IMPDH2 (0.35) IMPDH2GAAAXLEP300KAT2B
SCHEMBL31197276 0.76 EP300 (0.40) IMPDH2KDM4EGAAAXLEP300
SCHEMBL31306384 0.76 GOT1 (0.62) IMPDH2KDM4EGAAAXLEP300
SCHEMBL26667300 0.76 GOT1 (0.62) IMPDH2KDM4EGAAAXLEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302417-A NLRP3 inhibitors PTC医疗公司 2024-07-05 CN disclosed
CN-117580826-A NLRP3 inflammation corpuscle inhibitor 阿斯利康(瑞典)有限公司 2024-02-20 CN disclosed
WO-2022135567-A1 PYRIDAZINE-CONTAINING COMPOUND AND MEDICINAL USE THEREOF 上海拓界生物医药科技有限公司 2022-06-30 WO disclosed